Curcumin-loaded albumin submicron particles with potential as a cancer therapy: an in vitro study

• Nittiya Suwannasom,
• Netsai Sriaksorn,
• Chutamas Thepmalee,
• Krissana Khoothiam,
• Ausanai Prapan,
• Hans Bäumler and
• Chonthida Thephinlap

Beilstein J. Nanotechnol. 2023, 14, 1127–1140, doi:10.3762/bjnano.14.93

• cytotoxicity of CUR-HSA-MPs showed promising anticancer potential against human hepatocellular carcinoma (Huh-7) and human breast adenocarcinoma (MCF-7) cell lines, although this effect was less pronounced in human dermal fibroblasts (HDFB) and human cholangiocyte (MMN) cell lines. Confocal microscopy was used

• regulating the expression through a miRNA-mediated mechanism [4]. Furthermore, recent studies have shown that CUR induces apoptosis in human hepatocellular carcinoma cells (Huh-7) by activating p38, leading to FasL-associated apoptosis [5]. However, the clinical application of CUR is restricted by

• hepatocellular carcinoma (Huh-7) and human breast adenocarcinoma (MCF-7) cell lines using the colorimetric MTT assay. Human dermal fibroblasts (HDFB) and human cholangiocyte (MMNK-1) cell lines were evaluated as controls for cytotoxicity. Briefly, the cell lines were cultured in cell culture medium containing

Recent progress in cancer cell membrane-based nanoparticles for biomedical applications

• Qixiong Lin,
• Yueyou Peng,
• Yanyan Wen,
• Xiaoqiong Li,
• Donglian Du,
• Weibin Dai,
• Wei Tian and
• Yanfeng Meng

Beilstein J. Nanotechnol. 2023, 14, 262–279, doi:10.3762/bjnano.14.24

• bare NPs and erythrocyte membrane-encapsulated NPs [37]. Homologous targeting was not found in cells derived from normal tissues. Comparing NPs coated with hepatocellular carcinoma (HCC) HepG2 cell membrane and normal hepatocyte L02 cell membrane, only HepG2 cell membrane-coated NPs showed active

Effects of substrate stiffness on the viscoelasticity and migration of prostate cancer cells examined by atomic force microscopy

• Xiaoqiong Tang,
• Yan Zhang,
• Jiangbing Mao,
• Yuhua Wang,
• Zhenghong Zhang,
• Zhengchao Wang and
• Hongqin Yang

Beilstein J. Nanotechnol. 2022, 13, 560–569, doi:10.3762/bjnano.13.47

• pancreatic and hepatocellular carcinoma have also found that a stiffer ECM promotes EMT [13][14]. Therefore, the study of ECM stiffness has important implications for tumour metastasis. For prostate cancer, the current clinical approach to improving the positive biopsy rate is to incorporate ultrasound

Biocompatibility and cytotoxicity in vitro of surface-functionalized drug-loaded spinel ferrite nanoparticles

• Sadaf Mushtaq,
• Khuram Shahzad,
• Tariq Saeed,
• Anwar Ul-Hamid,
• Bilal Haider Abbasi,
• Nafees Ahmad,
• Waqas Khalid,
• Muhammad Atif,
• Zulqurnain Ali and
• Rashda Abbasi

Beilstein J. Nanotechnol. 2021, 12, 1339–1364, doi:10.3762/bjnano.12.99

• calculated by the formula given in Equation 4: Cell culture The cell lines human malignant melanoma (HT144, ATCC® HTB-63™) and human hepatocellular carcinoma (HepG2, ATCC®HB-8065™) were used in this study. The cells were grown in DMEM supplemented with 10% FCS and 1% GPPS in a humidified incubator (37 °C

Comprehensive review on ultrasound-responsive theranostic nanomaterials: mechanisms, structures and medical applications

• Sepand Tehrani Fateh,
• Lida Moradi,
• Elmira Kohan,
• Michael R. Hamblin and
• Amin Shiralizadeh Dezfuli

Beilstein J. Nanotechnol. 2021, 12, 808–862, doi:10.3762/bjnano.12.64

The impact of molecular tumor profiling on the design strategies for targeting myeloid leukemia and EGFR/CD44-positive solid tumors

• Nikola Geskovski,
• Nadica Matevska-Geshkovska,
• Simona Dimchevska Sazdovska,
• Marija Glavas Dodov,
• Kristina Mladenovska and
• Katerina Goracinova

Beilstein J. Nanotechnol. 2021, 12, 375–401, doi:10.3762/bjnano.12.31

Doxorubicin-loaded gold nanorods: a multifunctional chemo-photothermal nanoplatform for cancer management

• Uzma Azeem Awan,
• Abida Raza,
• Shaukat Ali,
• Rida Fatima Saeed and
• Nosheen Akhtar

Beilstein J. Nanotechnol. 2021, 12, 295–303, doi:10.3762/bjnano.12.24

• of death worldwide from which 9.6 million people died in 2018 [1]. Hepatocellular carcinoma (HCC) is one of the major types of liver cancer with high incidence of mortality [2]. Currently, there are a number of treatment modalities, including chemotherapy, immunotherapy, targeted therapy, irradiation

Poly(1-vinylimidazole) polyplexes as novel therapeutic gene carriers for lung cancer therapy

• Gayathri Kandasamy,
• Elena N. Danilovtseva,
• Vadim V. Annenkov and
• Uma Maheswari Krishnan

Beilstein J. Nanotechnol. 2020, 11, 354–369, doi:10.3762/bjnano.11.26

• indicating that silencing VEGF influences cell migration. Similar results have been reported for VEGF silencing in other cancer cells including hepatocellular carcinoma and pancreatic cancer [31]. Also, Boyden chamber assay measurements were carried out (Figure 11) in which the same trends were observed

Evaluation of click chemistry microarrays for immunosensing of alpha-fetoprotein (AFP)

• Seyed Mohammad Mahdi Dadfar,
• Sylwia Sekula-Neuner,
• Vanessa Trouillet,
• Hui-Yu Liu,
• Ravi Kumar,
• Annie K. Powell and
• Michael Hirtz

Beilstein J. Nanotechnol. 2019, 10, 2505–2515, doi:10.3762/bjnano.10.241

• -fetoprotein (AFP) is the most commonly used biomarker for early screening and diagnosis of hepatocellular carcinoma (HCC). Here, a combination of three techniques (click chemistry, the biotin–streptavidin–biotin sandwich strategy and the use of antigen–antibody interactions) were combined to implement a

• carcinoma; Introduction Hepatocellular carcinoma (HCC) is the major cause of morbidity and mortality in patients with chronic liver disease, the sixth most common cancer and the fourth leading cause of cancer-related deaths worldwide. The last release of the Global Cancer Observatory (GCO) database in

• was spotted onto them via microchannel cantilever spotting (µCS). Based on the fluorescence measurements, the optimal microarray design was found and its sensitivity was determined. Keywords: alpha-fetoprotein (AFP); cancer biomarker; click chemistry; fluorescent immunosensor; hepatocellular

Synthesis and potent cytotoxic activity of a novel diosgenin derivative and its phytosomes against lung cancer cells

• Liang Xu,
• Dekang Xu,
• Ziying Li,
• Yu Gao and
• Haijun Chen

Beilstein J. Nanotechnol. 2019, 10, 1933–1942, doi:10.3762/bjnano.10.189

• anticancer activities, such as restraining the hTERT gene expression in A549 lung cancer cells [3], inhibiting breast cancer stem-like cells via Wnt β-catenin signaling [4], impeding hepatocellular carcinoma cells by increasing DDX3 expression [5], and inducing apoptosis of prostate cancer cells through

Surface-enhanced Raman spectroscopy of cell lysates mixed with silver nanoparticles for tumor classification

• Mohamed Hassoun,
• Iwan W.Schie,
• Tatiana Tolstik,
• Sarmiza E. Stanca,
• Christoph Krafft and
• Juergen Popp

Beilstein J. Nanotechnol. 2017, 8, 1183–1190, doi:10.3762/bjnano.8.120

• male patient with well differentiated hepatocellular carcinoma and SK-Hep1 received from ascetic fluid of a patient with adenocarcinoma of the liver), one breast cancer cell line (MCF-7 obtained from a female patient) and one human pancreatic ductal adenocarcinoma cell line (Capan-1). A protocol was

Chitosan-based nanoparticles for improved anticancer efficacy and bioavailability of mifepristone

• Huijuan Zhang,
• Fuqiang Wu,
• Yazhen Li,
• Xiping Yang,
• Jiamei Huang,
• Tingting Lv,
• Yingying Zhang,
• Jianzhong Chen,
• Haijun Chen,
• Yu Gao,
• Guannan Liu and
• Lee Jia

Beilstein J. Nanotechnol. 2016, 7, 1861–1870, doi:10.3762/bjnano.7.178

• hepatocellular carcinoma) cells (Figure 7). CNs demonstrated no obvious toxicity to the four cancer cells under all the tested concentrations, indicating that Cs could be used as a safe drug carrier. However, MCNs could inhibit cell growth in a dose-dependant manner. In this experiment, we found that MIF had no